Rethink has committed to funding the Baby Time (POSITIVE) research trial in Canada!

This study, led by Dr. Karen Gelmon, Medical Oncologist, Department of Medical Oncology, BC Cancer Agency, will evaluate the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsive breast cancer who desire pregnancy.

Find out how you can support this study by clicking HERE.

In keeping with our pledge to connect and cultivate the most innovative minds in the fight against breast cancer, our one-of-a-kind research program fosters the talent of the most enterprising new breast cancer researchers in Canada.

Through our Career Development Awards, we provide promising young researchers and doctors the opportunity to pursue training in translational breast cancer research under the guidance and mentorship of the country’s leading scientists.

By extending our funding to researchers and clinical doctors, we are promoting an integrated and customized approach to breast cancer research – one that takes into account patients’ real-life experiences and concerns, not just the behaviour and characteristics of their cells.

We couldn’t think of a better way to draw fresh talent to breast cancer research, encourage innovative and holistic research projects and play a role in keeping our best and brightest in Canada.

Quick fact

Less than 3% of adult cancer patients participate in clinical trials.

Quick fact

For $35,000 to $70,000 per year, a Career Development Award can help a young researcher pursue a lifesaving project from beginning to end.

Quick fact

Research directed at understanding how and why tumours develop may result in new and effective methods of treatment that have fewer side effects than conventional chemotherapy.

Copyright   2003-2015  rethink  breast  cancer.  registered charity: #892176116RR0001